Breast Cancers
GI Cancers
Gynecologic Cancer
Immunology News
Head & Neck
Lung Cancers
Prostate Cancer

Latest News & Updates

Latest Articles
It is important that clinicians engage with social media, since reputations are at risk by not knowing what is being said, shared, and discussed online about them online.
Recent advances with immune checkpoint inhibitors could improve outcomes for patients with squamous cell non-small cell lung cancer, a traditionally hard to treat histology.
Steven Rosenberg always knew that he wanted to become a physician scientist, and he quickly advanced to become the chief of surgery at the National Cancer Institute (NCI) at just 34 years of age.
Over the past decade drug development in cancer has shifted to an increasingly gene target–based approach.
Adding 1-year of adjuvant trastuzumab to chemotherapy continues to demonstrate an improvement in overall survival (OS) and disease-free survival (DFS) for patients with early-stage HER2-positive breast cancer
Latest Peer Exchange Discussions
In this segment, H. Jack West, MD, discusses the dramatic benefit seen by some patients with non-small cell lung cancer who receive treatment with nivolumab. View Now
Brian I. Rini, MD, discusses clinical trials exploring PD-1 inhibitors in renal cell carcinoma, and the importance of proper side effect management with these novel agents. View Now
In this segment, Lecia Sequist, MD, MPH, talks about guidelines for mutation testing in lung cancer. View Now
Experts discuss utilizing pathologic complete response as an endpoint for clinical trials exploring treatments for patients with breast cancer. View Now
Online CME Activities
Free CME from PER
B-Cell Malignancies: Novel Agents, Emerging Treatment Strategies, and the Revolution of Care
Community Practice Connections: 15th Annual International Lung Cancer Congress®
Community Practice Connections: 13th Annual International Congress on the Future of Breast Cancer®
Highlights From the 13th Annual International Congress on the Future of Breast Cancer®